Newsroom
Sorted by: Latest
-
SES Delivers Robust Q1 2026 Results & Reiterates Full-Year Outlook
LUXEMBOURG--(BUSINESS WIRE)--SES S.A. announces financial results for the three months ended 31 March 2026. Q1 2026 Performance (€ million) Q1 2026 as reported (1) Q1 2025 as reported (1) ∆ At constant FX (2) Q1 2025 like-for-like(3) ∆ At constant FX (2) Average €/$ FX rate 1.18 1.04 1.04 Revenue 847 509 +80.5% 909 +3.1% Adjusted EBITDA (4) 404 280 +57.0% 425 +5.0% 1) ‘Reported basis’ with Intelsat fully consolidated from 17 July 2025 2) ‘At constant FX’ refers to comparative figures restat...
-
Number of Shares and Voting Rights of Innate Pharma as of April 16, 2026
MARSEILLE, France--(BUSINESS WIRE)--Number of shares and voting rights of Innate Pharma as of April 16, 2026...
-
Nouveau nombre d’actions et de droits de vote d’Innate Pharma au 16 avril 2026
MARSEILLE, France--(BUSINESS WIRE)--Regulatory News: Conformément aux articles L. 233-8 II du Code de Commerce et 223-16 du règlement général de l’Autorité des marchés financiers (l’« AMF »), Innate Pharma SA (Euronext Paris : IPH ; Nasdaq : IPHA) (« Innate » ou la « Société ») publie le nombre d’actions composant son capital social ainsi que le nombre de droits de vote associés au 16 avril 2026 : Nombre d’actions composant le capital : 93 934 210 actions dont : 93 921 863 actions ordinaires 4...
-
Tyler Technologies, Inc. Prices Upsized Offering of $1.25 Billion Convertible Senior Notes due 2031
PLANO, Texas--(BUSINESS WIRE)--Tyler Technologies, Inc. prices upsized offering of $1.25 billion convertible senior notes due 2031....
-
ACHTUNG - KORREKTUR : Volltext der Pressemitteilung folgt:Samsung Epis Holdings gibt Finanzergebnisse für das erste Quartal 2026 bekannt
INCHEON, Korea--(BUSINESS WIRE)--Samsung Epis Holdings (KRX: 0126Z0), eine Investmentgesellschaft, die sich auf Innovationen in den Bereichen Biopharmazeutika und Biotechnologie spezialisiert hat, gab heute ihre Finanzergebnisse für das erste Quartal des Geschäftsjahres 2026 bekannt. „Samsung Bioepis verzeichnete in diesem Quartal ein solides Wachstum, das von der anhaltenden Dynamik unseres Biosimilar-Portfolios getragen wurde“, sagte Kyung-Ah Kim, Präsidentin und Chief Executive Officer (CEO)...
-
注意-更正並替換:Samsung Epis Holdings公布2026年第一季財務業績
韓國仁川--(BUSINESS WIRE)--(美國商業資訊)-- 專注于生物製藥和生物科技創新的投資公司Samsung Epis Holdings (KRX: 0126Z0)今日公布了其2026會計年度第一季的財務業績。 Samsung Epis Holdings總裁兼執行長Kyung-Ah Kim表示:「憑藉生物相似藥產品組合的持續成長動力,Samsung Bioepis本季度實現穩健成長。我們正透過新的全球合作和持續的產品組合擴張,進一步鞏固市場地位。值此公司首款生物相似藥在歐洲上市十周年之際,我們將在既有基礎上再接再厲,同時展開策略性投資以支援長期發展。我們將持續致力於為股東創造永續價值。」 2026年第一季業績 按單獨基準計算,2026年第一季,Samsung Bioepis實現營收4549億韓元,營業利潤1440億韓元。第一季營收和營業利潤分別較去年同期成長14%(543億韓元)和13%(161億韓元)。 第一季整體增速較2025年1月發表的業績指引高出10%以上,反映出各項業務表現均優於預期。 Samsung Epis Holdings實現合併營收4539億韓元,營業利潤...
-
注意-更正并替换:Samsung Epis Holdings公布2026年第一季度财务业绩
韩国仁川--(BUSINESS WIRE)--(美国商业资讯)-- 专注于生物制药和生物技术创新的投资公司Samsung Epis Holdings (KRX: 0126Z0)今日公布了其2026财年第一季度的财务业绩。 Samsung Epis Holdings总裁兼首席执行官Kyung-Ah Kim表示:“依托生物类似药产品组合的持续增长动力,Samsung Bioepis本季度实现稳健增长。我们正通过新的全球合作和持续的产品组合扩张,进一步巩固市场地位。值此公司首款生物类似药在欧洲上市十周年之际,我们将在既有基础上再接再厉,同时开展战略性投资以支持长期发展。我们将持续致力于为股东创造可持续价值。” 2026年第一季度业绩 按单独基准计算,2026年第一季度,Samsung Bioepis实现营收4549亿韩元,营业利润1440亿韩元。第一季度营收和营业利润分别同比增长14%(543亿韩元)和13%(161亿韩元)。 第一季度整体增速较2025年1月发布的业绩指引高出10%以上,反映出各项业务表现优于预期。 Samsung Epis Holdings实现合并营收4539亿韩元,营业...
-
Citrix Introduces Citrix Platform Flex, a New Model Built to Tackle Modern IT Pressures With Persona‑based Computing
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Citrix today introduced Citrix® Platform Flex, a full‑stack secure access platform that brings together software, management, and infrastructure to deliver secure application access — including managed desktop services, enterprise browser and zero‑trust access. Built around workforce personas, Platform Flex replaces one‑size‑fits‑all licensing with a flexible consumption approach: customers purchase a pool of Flex credits and apply them to the right level...
-
Risewell Homes Schedules Earnings Conference Call for the Fiscal 2026 Second Quarter
IRVINE, Calif.--(BUSINESS WIRE)--Risewell Homes today announced that the Company will release its financial results for the fiscal 2026 second quarter on its confidential data site on Friday, May 15, 2026. The Company will also host a conference call beginning at 8:00 AM Pacific Time (11:00 AM Eastern Time) on Friday, May 15, 2026, to review the results, discuss recent events and conduct a question-and-answer period. The earnings release, investor presentation, conference call and webcast will...
-
Secure Code Warrior Signs Strategic Collaboration Agreement with AWS to Support Security-Conscious Developers with Amazon Bedrock AI Learning Modules
SYDNEY & BOSTON & LONDON--(BUSINESS WIRE)--Secure Code Warrior, a leader in AI software governance and developer security upskilling, announced it has signed a strategic collaboration agreement (SCA) with Amazon Web Services (AWS), and has launched new interactive, hands-on training modules now available within the Secure Code Warrior platform. The new modules enable developers and engineers to build Secure by Design habits, maintain continuous risk awareness, and adopt secure operational pract...